RxDoctor Payments DataLook up a doctor →

Randall Peyton, MD

Orthopaedic Surgery · Sterling, VANPI 1053392357

Payments from drug & device makers

$2,859,732in general payments, 2019–2025

Across 397 payments — averaging $7203.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$2.1M
  • Anika Therapeutics, Inc.$645K
  • Linkbio Corp$46K
  • Smith+Nephew$17K
  • Nextstep Arthropedix, LLC$558
  • Moximed, Inc$503
  • plus $1K from 18 others
$9,467in research payments, 2019–2025

Across 2 payments — averaging $4733.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amplitude Orthopedics Corporation$9K

What the payments were for

  • Royalty or licence$1,969,58169%
  • Consulting fees$212,7517%
  • Travel & lodging$25,3141%
  • Food & beverage$6,8330%
  • Ownership interest$570,55620%
  • Other$74,6973%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,859,732 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$906,669
Medicare patients
1,133
Services billed
25,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl22$372
Celecoxib27$202
Methylprednisolone26$164
Nabumetone16$153
Amoxicillin43$140
Mupirocin18$127
Meloxicam49$100
Tramadol Hcl21$70
Clindamycin Hcl15$49

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Sterling

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →